Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,399 | -38,696 | -29,154 | -16,486 | -7,324 |
| Depreciation Amortization | 5 | 26 | 19 | 13 | 6 |
| Accounts payable and accrued liabilities | 728 | 1,082 | -416 | -805 | N/A |
| Other Working Capital | -4,473 | 8,728 | 9,470 | -4,051 | -1,032 |
| Other Operating Activity | -205 | 96 | 1,232 | 1,162 | -28 |
| Operating Cash Flow | $-12,344 | $-28,764 | $-18,848 | $-20,169 | $-8,377 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -15 | -15 | N/A | N/A |
| Investing Cash Flow | $-5 | $-15 | $-15 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 75,847 | 59,843 | 24,627 | 11,375 |
| Financing Cash Flow | $0 | $75,847 | $59,843 | $24,627 | $11,375 |
| Exchange Rate Effect | -9 | -64 | -79 | -16 | -7 |
| Beginning Cash Position | 51,674 | 4,670 | 4,670 | 4,670 | 4,670 |
| End Cash Position | 39,317 | 51,674 | 45,571 | 9,112 | 7,660 |
| Net Cash Flow | $-12,357 | $47,005 | $40,901 | $4,442 | $2,991 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,344 | -28,764 | -18,848 | -20,169 | -8,377 |
| Capital Expenditure | -5 | -15 | -15 | N/A | N/A |
| Free Cash Flow | -12,348 | -28,779 | -18,863 | -20,169 | -8,377 |